Biomarkers for antitumor activity of bevacizumab in gastric cancer models

by Yamashita-Kashima, Yoriko, Fujimoto-Ouchi, Kaori, Yorozu, Keigo, Kurasawa, Mitsue, Yanagisawa, Mieko, Yasuno, Hideyuki, Mori, Kazushige
Published 2012

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts

by IWAI, TOSHIKI, MORIYA, YOICHIRO, SHIRANE, MASATOSHI, FUJIMOTO-OUCHI, KAORI, MORI, KAZUSHIGE
Published 2011

Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization

by Yamashita-Kashima, Yoriko, Shu, Sei, Yorozu, Keigo, Hashizume, Kaoru, Moriya, Yoichiro, Fujimoto-Ouchi, Kaori, Harada, Naoki
Published 2014

Erratum to: Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization

by Yamashita-Kashima, Yoriko, Shu, Sei, Yorozu, Keigo, Hashizume, Kaoru, Moriya, Yoichiro, Fujimoto-Ouchi, Kaori, Harada, Naoki
Published 2014

Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells

by Noguchi-Sasaki, Mariko, Sasaki, Yusuke, Shimonaka, Yasushi, Mori, Kazushige, Fujimoto-Ouchi, Kaori
Published 2016